[go: up one dir, main page]

DK1355928T3 - Universalbærer til målretning af molekyler mod GB3-receptor-udtrykkende celler - Google Patents

Universalbærer til målretning af molekyler mod GB3-receptor-udtrykkende celler

Info

Publication number
DK1355928T3
DK1355928T3 DK02700240T DK02700240T DK1355928T3 DK 1355928 T3 DK1355928 T3 DK 1355928T3 DK 02700240 T DK02700240 T DK 02700240T DK 02700240 T DK02700240 T DK 02700240T DK 1355928 T3 DK1355928 T3 DK 1355928T3
Authority
DK
Denmark
Prior art keywords
expressing cells
receptor
targeting molecules
universal carrier
cys
Prior art date
Application number
DK02700240T
Other languages
English (en)
Inventor
Ludger Johannes
Eric Tartour
Bruno Goud
Wolf Herve Fridman
Original Assignee
Inst Curie
Centre Nat Rech Scient
Inst Nat Sante Rech Med
Univ Paris Curie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Curie, Centre Nat Rech Scient, Inst Nat Sante Rech Med, Univ Paris Curie filed Critical Inst Curie
Application granted granted Critical
Publication of DK1355928T3 publication Critical patent/DK1355928T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/25—Shigella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
    • A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK02700240T 2001-02-01 2002-02-01 Universalbærer til målretning af molekyler mod GB3-receptor-udtrykkende celler DK1355928T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01400255A EP1229045A1 (en) 2001-02-01 2001-02-01 Universal carrier for targeting molecules to Gb3 receptor expressing cells
PCT/EP2002/001627 WO2002060937A1 (en) 2001-02-01 2002-02-01 Universal carrier for targeting molecules to gb3 receptor expressing cells

Publications (1)

Publication Number Publication Date
DK1355928T3 true DK1355928T3 (da) 2007-09-24

Family

ID=8182611

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02700240T DK1355928T3 (da) 2001-02-01 2002-02-01 Universalbærer til målretning af molekyler mod GB3-receptor-udtrykkende celler

Country Status (11)

Country Link
US (3) US7632514B2 (da)
EP (2) EP1229045A1 (da)
JP (1) JP4296536B2 (da)
AT (1) ATE362483T1 (da)
CA (1) CA2435712C (da)
CY (1) CY1106789T1 (da)
DE (1) DE60220136T2 (da)
DK (1) DK1355928T3 (da)
ES (1) ES2287239T3 (da)
PT (1) PT1355928E (da)
WO (1) WO2002060937A1 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1229045A1 (en) 2001-02-01 2002-08-07 Institut Curie Universal carrier for targeting molecules to Gb3 receptor expressing cells
EP1386927B1 (en) * 2002-08-02 2005-03-30 Institut Curie Shiga toxin B-subunit as a vector for tumor diagnosis and drug delivery to GB3 expressing tumors
GB0411411D0 (en) * 2004-05-21 2004-06-23 Glaxosmithkline Biolog Sa Vaccines
EP1938836A1 (en) * 2006-12-28 2008-07-02 Universite Rene Descartes (Paris V) Compositions comprising a B subunit of shiga toxin and a means stimulating NKT cells
GB0724360D0 (en) * 2007-12-14 2008-01-23 Glaxosmithkline Biolog Sa Method for preparing protein conjugates
GB0724357D0 (en) * 2007-12-14 2008-01-23 Glaxosmithkline Biolog Sa Method for preparing protein conjugates
US20090214438A1 (en) * 2007-12-18 2009-08-27 Institut Curie Methods and compositions for the preparation and use of toxin conjugates
EP2072060A1 (en) 2007-12-18 2009-06-24 Institut Curie Methods and compositions for the preparation and use of toxin conjugates.
EP2548571A1 (en) 2011-07-22 2013-01-23 Institut Curie Compositions having means for targeting at least one antigen to dendritic cells
EP2740491A1 (en) * 2012-12-05 2014-06-11 Institut Curie Conjugates of the B-subunit of shiga toxin for use as contrasting agents for imaging and therapy
EP2740493A1 (en) 2012-12-05 2014-06-11 Institut Curie Conjugates of the B-subunit of Shiga toxin for anticancer therapies
EP3058956A1 (en) 2015-02-23 2016-08-24 Institut Curie Combined vaccination/radioterapy for cancer treatment
JP2020519244A (ja) * 2017-04-20 2020-07-02 アンスティトゥート・ナシオナル・ドゥ・ラ・サンテ・エ・ドゥ・ラ・ルシャルシュ・メディカル・（インセルム） 研究及び生物医学応用のためのペプチド、特にポリペプチド、ファージディスプレイスクリーニング法及び関連する手段、並びにその使用
US20220233673A1 (en) 2019-06-04 2022-07-28 Institut Curie METHODS OF PRODUCING SHIGA TOXIN B-SUBUNIT (STxB) MONOMERS AND OLIGOMERS, AND USES THEREOF
US20240033366A1 (en) * 2020-12-02 2024-02-01 Institut Curie FUNCTIONALIZED SHIGA TOXIN B-SUBUNIT (STxB) PROTEINS AND CONJUGATES THEREOF
CN113754733B (zh) * 2021-09-18 2023-10-20 上海交通大学 一种vGPCR蛋白靶向肽的筛选方法及其嵌合毒素与应用
CN116236584B (zh) * 2023-02-20 2024-03-22 四川大学 一种用于高效递送siRNA的多糖-多肽偶联物

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4810643A (en) 1985-08-23 1989-03-07 Kirin- Amgen Inc. Production of pluripotent granulocyte colony-stimulating factor
AU8091694A (en) * 1993-10-26 1995-05-22 United Biomedical Inc. Structured synthetic antigen libraries as diagnostics, vaccines and therapeutics
DE4430601A1 (de) * 1994-08-22 1996-02-29 Beiersdorf Ag Zelladhäsions-Peptide zur Modifikation des Haftungsverhaltens eukaryontischer Zellen untereinander
WO1996030043A1 (en) * 1995-03-24 1996-10-03 Ophidian Pharmaceuticals Treatment for verotoxin-producing escherichia coli
DE19603649A1 (de) * 1996-02-01 1997-08-07 Werner Lubitz Rekombinante Expression von S-Layer-Proteinen
FR2766193B1 (fr) * 1997-07-18 2001-09-14 Inst Curie Polypeptide chimerique comprenant le fragment b de la toxine shiga et des peptides d'interet therapeutique
GB9808932D0 (en) * 1998-04-27 1998-06-24 Chiron Spa Polyepitope carrier protein
EP1229045A1 (en) * 2001-02-01 2002-08-07 Institut Curie Universal carrier for targeting molecules to Gb3 receptor expressing cells
EP1386927B1 (en) * 2002-08-02 2005-03-30 Institut Curie Shiga toxin B-subunit as a vector for tumor diagnosis and drug delivery to GB3 expressing tumors
AU2006248725A1 (en) * 2005-05-19 2006-11-23 Glaxosmithkline Biologicals S.A. Vaccine composition comprising B-subunit of E. coli heat toxin and an atigen and an adjuvant
GB0524409D0 (en) * 2005-11-30 2006-01-11 Glaxosmithkline Biolog Sa Vaccines
EP1991565B1 (en) * 2006-02-16 2015-01-21 The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. Shiga toxoid chimeric proteins
EP2420246A1 (en) * 2006-04-20 2012-02-22 The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. Methods and compositions based on shiga toxin type 1 protein
ES2520026T3 (es) * 2006-09-18 2014-11-11 The Board Of Trustees Of The University Of Arkansas Composiciones y métodos para potenciar respuestas inmunitarias
EP1938836A1 (en) * 2006-12-28 2008-07-02 Universite Rene Descartes (Paris V) Compositions comprising a B subunit of shiga toxin and a means stimulating NKT cells
EP2097529A4 (en) * 2006-12-29 2010-03-24 Osprey Pharmaceuticals Usa Inc METHOD FOR SELECTION AND PRODUCTION OF MODIFIED TOXINS, MODIFIED TOXINE CONJUGATES AND USES THEREOF
EP2145873A1 (fr) * 2008-06-17 2010-01-20 Commissariat A L'energie Atomique Nouveaux composés ayant une activité protectrice vis-à-vis de l'action de toxines et de virus au mode d'action intracellulaire
NZ593926A (en) * 2009-01-23 2013-03-28 Jackson H M Found Military Med Methods and compositions based on shiga toxin type 2 protein
PL2766193T3 (pl) 2011-10-14 2018-10-31 3Dtl, Inc. Element zabezpieczający lub dokument z cechą zabezpieczającą zawierający co najmniej jedną cechę z efektem dynamicznym

Also Published As

Publication number Publication date
EP1355928A1 (en) 2003-10-29
CY1106789T1 (el) 2012-05-23
PT1355928E (pt) 2007-08-23
JP2004531230A (ja) 2004-10-14
EP1355928B1 (en) 2007-05-16
JP4296536B2 (ja) 2009-07-15
CA2435712A1 (en) 2002-08-08
DE60220136T2 (de) 2008-01-24
CA2435712C (en) 2012-07-10
ES2287239T3 (es) 2007-12-16
US20100196418A1 (en) 2010-08-05
US9603923B2 (en) 2017-03-28
ATE362483T1 (de) 2007-06-15
DE60220136D1 (de) 2007-06-28
US20040110935A1 (en) 2004-06-10
US20150045536A1 (en) 2015-02-12
EP1229045A1 (en) 2002-08-07
US8852612B2 (en) 2014-10-07
US7632514B2 (en) 2009-12-15
WO2002060937A1 (en) 2002-08-08

Similar Documents

Publication Publication Date Title
DK1355928T3 (da) Universalbærer til målretning af molekyler mod GB3-receptor-udtrykkende celler
DE69807679D1 (de) Zusammensetzungen aus konjugaten des stabilen, aktiven, menschlichen ob proteins mit der fc kette von immunoglobulinen und damit zusammenhängende verfahren
BR0211926A (pt) agentes para realçar a resposta imune
ATE369878T1 (de) Träger-pharmaka-konjugate
IL195338A (en) An antibody comprising an FC variant containing amino acid replaces d or e at position 239, a medicament containing it and its use
ATE490311T1 (de) Mutanten der alpha-amylase
TR200101744T2 (tr) Fenilglisin türevleri.
UA84432C2 (ru) Очищенные пептиды и соединения, которые их содержат
BG102577A (bg) Нови 5-амино-3-циано-4-етилсулфинил-1-фенилпиразоли, метод за получаване и използването им като пестициди
DK1360203T3 (da) Antistoffer mod ikke-funktionel P2X7-receptordiagnose og behandling af cancerlidelser og andre tilstande
DE60326259D1 (de) Neue fructosylpeptidoxidase und deren nutzung
BR0011849A (pt) Anticorpos enxertados lm609 melhorados
ATE460429T1 (de) Polypeptide enthaltend extrazellulären domäne von il-20ra und/oderr il-20rb
DE69834741D1 (de) Cellulase aus actinomycetes und herstellungsverfahren dafür
DK1032686T3 (da) Cellulase dannet af Actinomyceter og fremgangsmåde til frembringelse heraf
WO2004019861A3 (en) Stable ph optimized formulation of a modified antibody
WO2003107009A3 (en) Methods for improving a binding characteristic of a molecule
DK1111385T4 (da) Enzym-protein-kompleks
NO995963D0 (no) Karboksamider anvendelige som 5-HTIF-agonister
BR0213779A (pt) Molécula de ácido nucleico isolada, vetor, célula hospedeira, e, método para a preparação de um composto de quìmica fina
DE69929454D1 (de) Neue aminosäuresequenzen, deren kodierende dns, antikörper dagegen und deren verwendungen
ATE326528T1 (de) Alkalische xyloglukanase aus malbranchea
DE60000856D1 (de) Selbstzerbrechliche spalierklammer
TR200001122T2 (tr) Farmasötikler olarak bifenil türevleri.
BR0109157A (pt) Dispositivo concentrador